Somatix, Inc. has filed a notice of an exempt offering of securities to raise $6 Million in New Funding.
According to filings with the U.S. Securities and Exchange Commission, Somatix, Inc. is raising up to $6,000,000.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.
About Somatix, Inc.
Somatix is an AI-powered digital health company founded on the belief that all patients deserve equitable, affordable, high-quality healthcare. Our technology is designed to detect early behavioral and emotional indicators of declining health and provide actionable clinical insights. Using its unique and patented gesture detection technology, Somatixs digital health platform enables providers to remotely and passively track for risk factors of adverse events, including poor medical compliance, falls, and dehydration. This novel, yet highly intuitive approach simplifies provider workflows and supports connected care through real-time remote patient monitoring and telemedicine capabilities.
To learn more about Somatix, Inc., visit https://www.somatix.com/
Somatix, Inc. Linkedin Page: https://www.linkedin.com/company/somatix/
Contact:
Charles Herman, President and Chief Executive Officer
929-256-4018
https://www.linkedin.com/in/charles-herman-md-mba-7555706/
SOURCE: http://www.intelligence360.io
Copyright (c) 2025 SI360 Inc. All rights reserved.
